Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular smooth muscle Ca2+-dependent ATPase and the myosin light chain phosphorylation machinery represent the integrated biochemical system responsible for regulating blood vessel diameter and peripheral resistance. The primary ATPase involved is the Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA2), which actively transports calcium ions from the cytosol into the sarcoplasmic reticulum to facilitate muscle relaxation [UniProt, 2023]. The phosphorylation machinery is centered on Myosin Light Chain Kinase (MLCK), an enzyme that becomes active upon binding to the Ca2+-calmodulin complex [Kamm & Stull, 1985]. Once active, MLCK phosphorylates the 20-kDa regulatory light chain of myosin, enabling cross-bridge formation with actin and resulting in vasoconstriction [Webb, 2003]. This process is balanced by Myosin Light Chain Phosphatase (MLCP), which promotes relaxation by removing the phosphate group, a process regulated by the Rho-kinase pathway [Somlyo & Somlyo, 2003]. Dysregulation of this system, often characterized by increased MLCK activity or decreased SERCA function, is a fundamental mechanism in the pathogenesis of hypertension and vasospastic disorders [PubMed, 2018]. Pharmacological agents like magnesium sulfate, nitrates, and Rho-kinase inhibitors target various points in this machinery to modulate vascular tone and treat cardiovascular conditions.
Regulation of vascular smooth muscle tone through the control of intracellular calcium levels (via ATPase-mediated sequestration) and the phosphorylation state of the myosin light chain (via kinase/phosphatase activity).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle Ca2+-dependent ATPase and myosin light chain phosphorylation machinery.